MetaMask users are at risk of a new “2FA verification” phishing scam that steals their seed phrase under the guise of improving security. According to blockchainMetaMask users are at risk of a new “2FA verification” phishing scam that steals their seed phrase under the guise of improving security. According to blockchain

MetaMask users targeted by fake 2FA phishing scam that steals seed phrases

2026/01/05 16:20
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

MetaMask users are at risk of a new “2FA verification” phishing scam that steals their seed phrase under the guise of improving security.

Summary
  • MetaMask users are being targeted by a phishing campaign involving a fake 2FA verification process.
  • The new campaign comes on the heels of a large-scale wallet exploit and the Trust Wallet Chrome extension incident.

According to blockchain security firm SlowMist, MetaMask users are receiving a spoofed email that creates a false sense of urgency by prompting them to enable Two-Factor Authentication. The message is MetaMask-branded and appears convincing at first glance. (See below.)

A spoof email sent by attackers.

Notably, the malicious notifier also comes with a countdown timer, which increases pressure on the user and attempts to force a quick response.

Upon clicking the “Enable 2FA Now” button, users are redirected to a fake page hosted by the attacker. However, in reality, the entire process is a sham. The main goal is to trick MetaMask users into entering their mnemonic phrase, which attackers can use to access and transfer funds from their wallets. (See below.)

Malicious website asking users to input their seed phrase.

While at first glance a less cautious user may fall for this scheme, the spoof email contains several giveaways that can help users spot the fraud.

For instance, such phishing messages often include subtle typos or design inconsistencies that can reveal their true nature. In this case, the URL to which MetaMask users were redirected was spelled as “mertamask” instead of “metamask.” In some cases, these emails are also sent from completely unrelated email accounts, or from addresses using public domains like Gmail. (See below.)

Typos within spoof emails.

Lastly, it is important to remember that MetaMask does not send unsolicited emails asking users to verify their accounts or perform security updates. Any such requests are typically scams.

Recent phishing campaigns targeting crypto users

Late last week, cybersecurity researcher Vladimir S. flagged a similar campaign that pushed a fake MetaMask app update. It is believed to be connected to an ongoing wallet-draining exploit.

According to on-chain sleuth ZachXBT, the incident resulted in losses of less than $2,000 per wallet but affected a wide range of users across several EVM-compatible networks. However, it has not been confirmed whether the two campaigns are definitely connected.

The incident was also linked to the Trust Wallet hack that occurred on Christmas Day, where losses climbed to roughly $7 million. 

The attacker managed to gain access to the wallet’s browser extension source code and uploaded a malicious version of the extension to the Chrome Web Store. Trust Wallet has vowed to compensate all users affected by the incident.

Separately, Cardano users were also warned about a different ongoing attack that circulated emails promoting a fraudulent Eternl Desktop application.

Despite these events all happening within less than two weeks, a recent Scam Sniffer report showed that total losses from crypto phishing campaigns dropped nearly 88% in 2025 from the previous year.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09